Press Releases

The Unilens Vision Inc.Board of Directors today declared a quarterly cash dividend of $0.045 per common share, payable February 24,2012 to stockholders of record at the close of business on February 10, 2012. About...

Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, granted final approval for the Company's Abbreviated New Drug Application, for Lorazepam oral concentrate 2mg/mL, the generic for Roxanne’s Lorazepam Intensol®...

PharMerica Corporation , a national provider of institutional pharmacy and hospital pharmacy management services, today commented on the decision by the Federal Trade Commission to sue to block Omnicare’s  unsolicited offer to acquire PharMerica. ...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the promotions of Rick Gonzalez to Senior Vice President, Commercial; Andrew W. Amstrup...

Greenleaf Health LLC today announced that Michael Chappell, former Acting Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (“FDA”), has joined the firm as Senior Advisor. Greenleaf Health is a full service...

Rhenovia Pharma SAS, a biotechnology company specializing in biosimulation applied to the discovery of new medications to treat brain diseases such as Alzheimer’s, today announces its first international subsidiary, Rhenovia Inc, incorporated in Delaware. Rhenovia’s new...

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced the termination of certain license agreements with Talon Therapeutics, Inc. and Par Pharmaceutical Companies, Inc., relating to the development and commercialization...